The Next Generation Biotech Media
By Vicky Su On July 7th, 2020, Regeneron Pharmaceuticals, Inc. announced that the Trump administration has awarded them a $4.5 billion contract to manufacture and supply REGN-COV2, an investigational antibody …
Read More
Several drugs have recently been repurposed to control the COVID-19 pandemic. Now two more drugs, Alvesco and Avigan, are under clinical trials to see whether they could help patients with …
Read More
On March 24, 2020, AnGes, Inc, a Japanese biopharmaceutical company, announced that it had completed the development of a DNA vaccine against COVID-19 with Osaka University and it would start …
Read More
Korean scientists claim that a lactic acid bacteria from sea buckthorn berries, could potentially inhibit the proliferation of SARS-CoV-2 by repressing purine activation. Lactobacillus species in the gut microbiota have …
Read More
South Koreas’ Ministry of Food and Drug Safety has approved the application from Seoul National University Hospital (SNUH) and ImmuneMed to use its patented virus suppressing factor (VSF) as a …
Read More
Argonaute (AGO) proteins bind to short interfering RNAs (siRNAs) or microRNAs (miRNAs) and form the core of the RNA-induced silencing complex (RISC). Although the function of the AGO proteins in …
Read More